A) Market Overview:
The global Perfusion System Market is estimated to be valued at USD 1.07 Billion In 2022 and is expected to exhibit a CAGR Of 4.7% over the forecast period from 2023 to 2030. Perfusion systems are medical devices used to preserve organs and tissues outside the body by continuously circulating oxygenated blood or other fluids, allowing them to remain viable for transplantation. These systems provide numerous advantages, including improved organ quality, extended preservation time, and increased success rates in transplant surgeries. With the rising demand for organ transplantation across the globe, the need for efficient perfusion systems is increasing, driving the market growth.
B) Market key trends:
One key trend observed in the Perfusion System Market is the development of portable and miniaturized perfusion systems. These systems offer the advantage of mobility and ease of use, allowing organ preservation and transportation in remote or resource-limited areas. Portable perfusion systems enable healthcare professionals to transport organs over long distances without compromising their viability, improving accessibility to transplantation procedures. Moreover, the miniaturization of perfusion systems allows for organ preservation in limited spaces, such as ambulances or helicopters, ensuring timely delivery to transplant centers. The growing focus on expanding access to organ transplantation and addressing geographical barriers is driving the adoption of portable and miniaturized perfusion systems in the market.
Segment Analysis:
The perfusion system market can be segmented based on technology, organ type, and region. Based on technology, the market is further segmented into hypothermic machine perfusion, normothermic machine perfusion, and others. The hypothermic machine perfusion segment is expected to dominate the market during the forecast period. This is primarily due to its advantages such as preservation of organs at low temperatures, reducing the risk of ischemic reperfusion injury, and maintaining organ viability. Additionally, the increasing number of organ transplants and the rising demand for technologically advanced perfusion systems are driving the growth of this segment.
Key Takeaways:
The global perfusion system market is expected to witness high growth, exhibiting a CAGR of 4.7% over the forecast period. This growth can be attributed to the increasing number of organ transplants and advancements in perfusion technology. The market is projected to reach USD 1.07 billion in 2022.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the perfusion system market. This can be attributed to the well-established healthcare infrastructure, technological advancements, and increasing organ transplant procedures in the region. Europe is also expected to witness significant growth due to the rising awareness about organ donation and the presence of key market players in the region.
Key players operating in the perfusion system market include XVIVO Perfusion AB, Paragonix Technologies, Inc., Organ Assist B.V., Organ Recovery Systems, Organ Transport Systems, Waters Medical Systems, TransMedics, Inc., OrganOx Limited, and Bridge to Life Ltd. These players are focusing on strategic partnerships, product launches, and technological advancements to strengthen their market position and expand their product portfolio.
In conclusion, the global perfusion system market is expected to witness substantial growth in the coming years. Advancements in perfusion technology and the increasing number of organ transplants are driving the demand for perfusion systems. North America and Europe are expected to be the dominant regions in the market, and key players are adopting strategies to stay competitive and meet the growing market demand.
COVID-19 Impact Analysis on Organ and Tissue Transplantation Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the organ and tissue transplantation market include NHS Blood and Transplant, Tissue Services, U.K., LifeCell Corporation, Mid-America Transplant Services, Australian Red Cross Blood Service, Acelity L.P. Inc., CryoLife, Inc., Exactech Inc., Folio Biosciences, LLC Dr. Franz Kohler Chemie GmbH, etc.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Organ and Tissue Transplantation Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/organ-and-tissue-transplantation-market/download-sampleMarket DynamicsThe global organ and tissue transplantation market is expanding with the consequences of the rising burden of non-communicable diseases, geriatric population, and other risk exposures.
High incidence and prevalence of diseases such as cardiovascular diseases, diabetes, cancer, renal diseases, and Alzheimer’s disease most probably cause organ failure to contribute to the growing market revenue.
However, the high cost of the procedure, lack of donors, and threat of implant failure are restraining the worldwide organ and tissue transplantation market growth.’The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
